Market
  • Company Info.

    Evoq Remedies Ltd.

    Directors Report



    Market Cap.(`) 14.36 Cr. P/BV 0.58 Book Value (`) 18.22
    52 Week High/Low ( ` ) 19/9 FV/ML 10/4000 P/E(X) 8.87
    Book Closure EPS (`) 1.19 Div Yield (%) 0.00
    You can view full text of the latest Director's Report for the company.
    Year End :2023-03

    DIRECTOR'S REPORT

    To,

    The Members,

    Evoq Remedies Limited

    Your Directors hereby present the 13th Board's Report on the Business and Operations of the
    Company together with the Audited Financial Statements along with the Auditor's Report for the
    Financial Year ended on 31st March, 2023.

    1. FINANCIAL RESULTS:

    The financial performance of the Company for the Financial Year ended on 31st March, 2023 is
    summarized as below:

    Particulars

    2022-23

    2021-22

    Revenue from Operations

    2038.99

    1678.31

    Other Income

    602.27

    0.00

    Total Income

    2641.26

    1678.31

    Total Expenses

    2412.81

    1532.47

    Profit Before Exceptional and Extra Ordinary Items
    and Tax

    228.45

    145.84

    Exceptional and Extra Ordinary Items

    0.00

    0.00

    Profit Before Tax

    228.45

    145.84

    Tax Expense: Current Tax

    66.52

    36.71

    Deferred Tax

    0.00

    0.00

    Profit for the Period / After T ax

    161.93

    109.13

    Earnings Per Share (EPS)

    Basic

    1.19

    0.70

    Diluted

    1.19

    0.70

    2. OPERATIONS:

    Total revenue from operations for Financial Year 2022-23 is Rs. 2641.26 Lakhs compared to the
    total revenue from operations of Rs. 1678.31 Lakhs of previous Financial Year. The Company
    has incurred Profit before tax for the Financial Year 2022-23 of Rs. 228.45 Lakhs as compared to
    Profit of Rs. 145.84 Lakhs of previous Financial Year. Net Profit after Tax for the Financial Year
    2022-23 is Rs. 161.93 Lakhs as against Net Profit of Rs. 109.13 Lakhs of previous Financial Year.
    The Directors are continuously looking for the new avenues for future growth of the Company
    and expect more growth in the future period.

    3. CHANGE IN NATURE OF BUSINESS, IF ANY:

    There is no change in the nature of business during the year under review.

    4. WEBLINK OF ANNUAL RETURN:

    Pursuant to Section 92(3) read with Section134(3)(a) of the Act, the Annual Return as on March
    31, 2023 is available on the Company's website at
    www.evoqremedies.com.

    5. SHARE CAPITAL:A. AUTHORISED SHARE CAPITAL:

    The authorised Equity share capital of the Company as on 31st March, 2023 is Rs.

    16.00. 00.000/- (Rupees Sixteen Crores Only) divided into 1,60,00,000 (One Crore Sixty
    Lakhs) Equity Shares of Rs. 10/- (Rupees Ten Only) each.

    B. PAID-UP SHARE CAPITAL:

    The paid-up Equity share capital of the Company as on 31st March, 2023 is Rs.

    13.60.00. 000/- (Rupees Thirteen Crores Sixty Lakhs Only) divided into 1,36,00,000 (One
    Crore Thirty Six Lakhs) equity shares of Rs. 10/- (Rupees Ten Only).

    6. CHANGE OF REGISTERED OFFICE OF THE COMPANY:

    Registered office of the Company is changed from F-12-A, First Floor, V R Complex, Near
    Sanathal Cross Road, Sanathal Ahmedabad - 382 210 to A-1106, Empire Business Hub Near
    AUDA Water Tank, Science City Road, Sola, Ahmedabad, Gujarat - 380 060 with effect from 3rd
    September, 2022.

    7. DIVIDEND:

    To conserve the resources for future prospect and growth of the Company, your directors do not
    recommend any dividend for the Financial Year 2022-23 (Previous year - Nil).

    8. TRANSFER OF UNCLAIMED DIVIDEND TO INVESTOR EDUCATION AND PROTECTION
    FUND:

    Pursuant to Section 124 of the Companies Act, 2013, the amount of dividend remaining unpaid
    or unclaimed for a period of seven years shall be transferred to the Investor Education and
    Protection Fund (“IEPF”). During the year under review, there was no unpaid or unclaimed
    dividend in the “Unpaid Dividend Account” lying for a period of seven years from the date of
    transfer of such unpaid dividend to the said account. Therefore, there were no funds which were
    required to be transferred to Investor Education and Protection Fund.

    9. TRANSFER TO RESERVES:

    The profit of the Company for the Financial Year ending on 31st March, 2023 is transferred to
    profit and loss account of the Company under Reserves and Surplus.

    10. MATERIAL CHANGES AND COMMITMENTS, IF ANY, AFFECTING THE FINANCIAL
    POSITION OF THE COMPANY WHICH HAVE OCCURRED BETWEEN THE END OF THE
    FINANCIAL YEAR TO WHICH THE FINANCIAL STATEMENTS RELATES AND THE DATE OF
    THE REPORT:

    There have been no material changes and commitments, which affect the financial position of
    the Company which have occurred between the end of the financial year to which the financial
    statements relate and the date of this Report.

    11. SIGNIFICANT & MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR
    TRIBUNALS:

    There are no significant material orders passed by the Regulators or Courts or Tribunal, which
    would impact the going concern status of the Company and its future operation.

    12. MEETINGS OF THE BOARD OF DIRECTORS:

    The Directors of the Company met at regular intervals at least once in a quarter with the gap
    between two meetings not exceeding 120 days to take a view of the Company's policies and
    strategies apart from the Board Matters.

    During the year under the review, the Board of Directors met 4 (Four) viz., 30th May, 2022, 3rd
    September, 2022, 7th November, 2022 and 31st March, 2023.

    13. DIRECTORS RESPONSIBILITYSTATEMENT:

    In accordance with the provisions of Section 134 (3)(c) and Section 134(5) of the Companies
    Act, 2013, to the best of their knowledge and belief the Board of Directors hereby submit that:

    a In the preparation of the Annual Accounts, for the year ended on 31st March, 2023 the
    applicable accounting standards read with requirements set out under Schedule III to the
    Act, have been followed and there are no material departure from the same;

    b. The Directors had selected such accounting policies and applied them consistently and
    made judgments and estimates that are reasonable and prudent so as to give a true and fair
    view of the state of affairs of the Company at the end of financial year and of the profit of
    the Company for the financial year ended on 31st March, 2023.

    c. The Directors had taken proper and sufficient care for the maintenance of adequate
    accounting records in accordance with the provisions of Companies Act, 2013 for
    safeguarding the assets of the Company and for preventing and detecting fraud and other
    irregularities;

    d. The Directors had prepared the Annual Accounts on a going concern basis;

    e. The Directors had laid down internal financial controls to be followed by the Company and
    that such internal financial controls are adequate and are operating effectively and

    £ The Directors had devised proper systems to ensure compliance with the provisions of all
    applicable laws and that such systems were adequate and operating effectively.

    14. CORPORATE SOCIAL RESPONSIBILITY (CSR):

    The provisions of section 135 of the Companies Act, 2013 is not applicable to your Company as
    the Company does not fall under the criteria limits mentioned in the said section of the Act.

    Hence, the Company has not taken voluntary initiative towards any activity mentioned for
    Corporate Social Responsibility.

    15. EXPLANATIONS / COMMENTS BY THE BOARD ON EVERY QUALIFICATION,
    RESERVATION OR ADVERSE REMARK OR DISCLAIMER MADE:
    i. Auditors' Report and Qualified Report:Query 1:

    The company has not complied provisions of section 185 and 186 of Companies Act, 2013 in

    following cases in annexure:

    Reply 1:

    There is no need to comply the provisions of the section 185 & 186 of the companies act
    2013 as the said advances are for business purpose like trading of goods etc.,

    Query 2:

    The loans granted are re-payable on demand. As informed, the company has not demanded
    Repayment of any such loan during the year, thus, there has been no default on the part of
    the parties to whom the money has been lent. However no interest have been charged.

    Reply 2:

    Interest on Unsecured Loan was not provided because promoter wants to help the
    company.

    Query 3:

    According to the information and explanations given to us and on an overall examination of
    the balance sheet of the Company, we report that funds have been raised on short-term
    basis (Rs. 9.57 Crores) by the Company and same have been utilised for advances to the
    creditors (Rs. 7.34 Crores) for which no explanation given.

    Reply 3:

    The Fund raised on short term basis Rs. 9.57 Crores by company have been utilized for
    purchase of goods and said funds are not from public or bank but from promoter group.

    Query 4:

    The company is regular in depositing with appropriate authorities undisputed statutory
    dues including Provident Fund, Employees' State Insurance, Income Tax, Sales-Tax, Service
    Tax, Duty of Customs, Duty of Excise, Value Added Tax, Cess and any other statutory dues
    applicable to it, except regular income tax demand Rs. 86.72 Lakhs.

    Reply 4:

    The Demand of income tax not paid due to financial crisis and major fund involve in debtors
    And stock. It will be paid within short time.

    Query 5:

    All transactions with the related parties are in compliance with section 177 and 188 of
    Companies Act, 2013 where applicable and the details have been disclosed in the Financial
    Statements etc., as required by the applicable accounting standards.

    Reply 5:

    Related party transactions are routine business transactions.

    Query 6:

    Whether moneys raised by way of initial public offer or further public offer (including debt
    instruments) and term loans were applied for the purposes for which those are raised. If
    not, the details together with delays or default and subsequent rectification? if any, as may
    be applicable, be reported.

    Reply 6:

    The Fund Utilized as per DRHP for the working capital purpose.

    The other observations of the Statutory Auditor, when read together with the relevant notes to
    the accounts and accounting policies are self-explanatory and do not calls for any further
    comment.

    ii. Secretarial Auditor's Report:

    The observation of the Secretarial Auditor, as per Secretarial Report i.e. MR-3 and do not calls
    for any further comment.

    16. PARTICULARS OF LOANS, GUARANTEES, SECURITIES COVERED OR INVESTMENTS
    MADE UNDER SECTION 186 OF THE COMPANIES ACT, 2013:

    The details of loans, investment, guarantees and securities covered under the provisions of
    section 186 of the Companies Act, 2013 are provided in the financial statement.

    17. PARTICULARS OF CONTRACTS OR ARRANGEMENTS MADE WITH RELATED PARTIES:

    All transactions to be entered by the Company with related parties will be in the ordinary -
    Course of business and on an arm's length basis. Further, Particulars of contract or arrangement
    with related parties referred to in section 188(1) of the Companies Act, 2013 read with Rule
    8(2) of the Companies (Accounts) Rules, 2014, in Form No. AOC-2 is enclosed herewith as
    Annexure I.

    18. MANAGEMENT DISCUSSION AND ANALYSIS REPORT:

    The Management Discussion and Analysis Report as required under Regulation 34 and Schedule
    V of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 forms an
    integral part of this Report, and provides the Company's current working and future outlook as
    per
    Annexure - II.

    19. INTERNAL FINANCIAL CONTROL SYSTEMS AND THEIR ADEQUACY:

    The Company has in place adequate internal financial controls with reference to financial
    statement across the organization. The same is subject to review periodically by the internal
    audit cell for its effectiveness. During the financial year, such controls were tested and no
    reportable material weaknesses in the design or operations were observed. The Statutory
    Auditors of the Company also test the effectiveness of Internal Financial Controls in accordance
    with the requisite standards prescribed by ICAI. Their expressed opinion forms part of the
    Independent Auditor's report.

    Internal Financial Controls are an integrated part of the risk management process, addressing
    financial and financial reporting risks. The internal financial controls have been documented,
    digitized and embedded in the business processes.

    Assurance on the effectiveness of internal financial controls is obtained through management
    reviews, control self-assessment, continuous monitoring by functional experts. We believe that
    these systems provide reasonable assurance that our internal financial controls are designed
    effectively and are operating as intended.

    During the year, no reportable material weakness was observed.

    20. RESERVES & SURPLUS:

    Sr. No.

    Particulars

    Amount

    1.

    Balance at the beginning of the year

    112.43

    2.

    Securities Premium account

    844.20

    3.

    Current Year's Profit / Loss

    161.93

    Total

    1118.55

    21. STATEMENT CONCERNING DEVELOPMENT AND IMPLEMENTATION OF THE RISK
    MANAGEMENT POLICY OF THE COMPANY:

    The Company has framed formal Risk Management framework for risk assessment and risk
    minimization for Indian operation which is periodically reviewed by the Board of Directors to
    ensure smooth operations and effective management control. The Audit Committee also reviews
    the adequacy of the risk management frame work of the Company, the key risks associated with
    the business and measures and steps in place to minimize the same.

    22. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE
    EARNINGS AND OUTGO:

    The details of conservation of energy, technology absorption etc. as required to be given under
    section 134(3)(m) of the Companies Act 2013 read with the Companies (Accounts) Rules, 2014,
    is not given as the Company has not taken any major step to conserve the energy etc.

    There were no foreign exchange earnings or outgo during the year under review.

    Sr. No.

    Foreign exchange earnings and outgo

    F.Y. 2022-23

    F.Y. 2021-22

    1.

    Foreign exchange earnings

    Nil

    Nil

    2.

    CIF value of imports

    Nil

    Nil

    3.

    Expenditure in foreign currency

    Nil

    Nil

    4.

    Value of Imported and indigenous Raw Materials,
    Spare-parts and Components Consumption

    Nil

    Nil

    23. POLICY ON DIRECTOR'S APPOINTMENT AND REMUNERATION:

    The Remuneration policy is directed towards rewarding performance based on review of
    achievements on a periodical basis. The remuneration policy is in consonance with the existing
    industry practice and is designed to create a high-performance culture. It enables the Company
    to attract, retain and motivate employees to achieve results. The Company has made adequate
    disclosures to the members on the remuneration paid to Directors from time to time. The
    Company's Policy on director's appointment and remuneration including criteria for
    determining qualifications, positive attributes, independence of a director and other matters
    provided under Section 178 (3) of the Act is available on the website of the Company at
    www.evoqremedies.com.

    24. DISCLOSURES RELATING TO HOLDING, SUBSIDIARY, ASSOCIATE COMPANY AND
    JOINT VENTURES:

    The Company does not have any Holding / Subsidiary / Associate Company and Joint Venture.

    25. SECRETARIAL STANDARDS:

    During the year under review, the Company has complied with the applicable Secretarial
    Standards issued by the Institute of Company Secretaries of India (ICSI). The Company has
    devised proper systems to ensure compliance with its provisions and is in compliance with the
    same.

    26. REPORTING OF FRAUDS BY THE AUDITORS:

    During the year under review, neither the Statutory nor the Secretarial Auditors has reported to
    the Audit Committee under Section 143(12) of the Companies Act, 2013 any instances of fraud
    committed against the Company by its officers or employees, the details of which would need to
    be mentioned in the Board's Report.

    27. STATE OF COMPANY'S AFFAIRS:

    Management Discussion and Analysis Report for the year under review, as stipulated in
    Regulation 34(2)(e) of SEBI Listing Regulations is given as a separate part of the Annual Report.
    It contains a detailed write up and explanation about the performance of the Company.

    28. STATEMENT ON ANNUAL EVALUATION OF BOARD'S PERFORMANCE:

    The Board evaluated the effectiveness of its functioning, that of the Committees and of
    individual Directors, pursuant to the provisions of the Act and SEBI Listing Regulations. The
    Board sought the feedback of Directors on various parameters including:

    • Degree of fulfillment of key responsibilities towards stakeholders (by way of monitoring
    corporate governance practices, participation in the long-term strategic planning, etc.);

    • Structure, composition, and role clarity of the Board and Committees;

    • Extent of co-ordination and cohesiveness between the Board and its Committees;

    • Effectiveness of the deliberations and process management;

    • Board / Committee culture and dynamics; and

    • Quality of relationship between Board Members and the Management.

    The above criteria are broadly based on the Guidance Note on Board Evaluation issued by the
    Securities and Exchange Board of India on January 5, 2017.

    The Chairman of the Board had one-on-one meetings with each Independent Director and the
    Chairman of the Nomination and Remuneration Committee had one-on-one meetings with each
    Executive and Non-Executive, Non-Independent Directors. These meetings were intended to
    obtain Directors' inputs on effectiveness of the Board/ Committee processes.

    In a separate meeting of Independent Directors, performance of Non-Independent Directors, the
    Board as a whole, and the Chairman of the Company was evaluated, taking into account the
    views of Executive Directors and Non-Executive Directors.

    The Nomination and Remuneration Committee reviewed the performance of the individual

    directors and the Board as a whole.

    In the Board meeting that followed the meeting of the independent directors and the meeting of
    Nomination and Remuneration Committee, the performance of the Board, its committees, and
    individual directors was discussed.

    The evaluation process endorsed the Board Members' confidence in the ethical standards of the
    Company, the resilience of the Board and the Management in navigating the Company during
    challenging times, cohesiveness amongst the Board Members, constructive relationship between
    the Board and the Management, and the openness of the Management in sharing strategic
    information to enable Board Members to discharge their responsibilities and fiduciary duties.

    The Board carried out an annual performance evaluation of its own performance and that of its
    committees and individual directors as per the formal mechanism for such evaluation adopted
    by the Board. The performance evaluation of all the Directors was carried out by the Nomination
    and Remuneration Committee.

    The performance evaluation of the Chairman, the Non-Independent Directors and the Board as a
    whole was carried out by the Independent Directors. The exercise of performance evaluation
    was carried out through a structured evaluation process covering various aspects of the Board
    functioning such as composition of the Board & committees, experience & competencies,
    performance of specific duties & obligations, contribution at the meetings and otherwise,
    independent judgment, governance issues etc.

    Pursuant to the provisions of the Companies Act, 2013 and SEBI (Listing Obligation and
    Disclosure Requirements) Regulations, 2015, the Board has carried out the annual performance
    evaluation of the Directors individually as well as evaluation of the working of the Board by way
    of individual feedback from directors.

    The evaluation frameworks were the following key areas:

    a) For Non-Executive & Independent Directors:

    • Knowledge

    • Professional Conduct

    • Comply Secretarial Standard issued by ICSI Duties

    • Role and functions

    b) For Executive Directors:

    • Performance as leader

    • Evaluating Business Opportunity and analysis of Risk Reward Scenarios

    • Key set investment goal

    • Professional conduct and integrity

    • Sharing of information with Board.

    • Adherence applicable government law

    The Directors expressed their satisfaction with the evaluation process.

    29. MANAGING THE RISKS OF FRAUD, CORRUPTION AND UNETHICAL BUSINESS
    PRACTICES:
    A. VIGIL MECHANISM / WHISTLE BLOWER POLICY:

    The Company has established vigil mechanism and framed whistle blower policy for
    Directors and employees to report concerns about unethical behavior, actual or
    suspected fraud or violation of Company's Code of Conduct or Ethics Policy.

    B. BUSINESS CONDUCT POLICY:

    The Company has framed “Business Conduct Policy”. Every employee is required to
    review and sign the policy at the time of joining and an undertaking shall be given for
    adherence to the policy. The objective of the policy is to conduct the business in an
    honest, transparent and in an ethical manner. The policy provides for anti-bribery and
    avoidance of other corruption practices by the employees of the Company.

    30. PARTICULARS OF EMPLOYEES:

    The provisions of Rule 5(2) & (3) of the Companies (Appointment & Remuneration of
    Managerial Personnel) Rules, 2014 are not applicable to the Company as none of the Employees
    of the Company has received remuneration above the limits specified in the Rule 5(2) & (3) of
    the Companies (Appointment & Remuneration of Managerial Personnel) Rules, 2014 during the
    financial year 2022-23.

    31. LOAN FROM DIRECTOR / RELATIVE OF DIRECTOR:

    During the year under review, the Company has not entered into any materially significant
    related party transactions which may have potential conflict with the interest of the Company at
    large. Suitable disclosures as required are provided in AS-18 which is forming the part of the
    notes to financial statement.

    32. DIRECTORS AND KEY MANAGERIAL PERSONNEL

    The Directors and Key Managerial Personnel of the Company are summarized below:

    Sr. No.

    Name

    Designation

    DIN

    1.

    Ms. Payal Patel5

    Non-Executive Director

    05300011

    2.

    Mr. Dahyabhai Patel35

    Managing Director

    07061899

    3.

    Mr. Pranav Vajani

    Independent Director

    09213749

    4.

    Mr. Digesh Deshaval

    Independent Director

    09218553

    5.

    Mr. Yogesh Rajput

    CFO

    ADSPR1053K

    6.

    Mr. Bhumishth Patel25

    Managing Director

    02516641

    7.

    Mr. Tarunkumar Patel3

    Non-Executive Director

    09433349

    8.

    Mr. Tej Hanj1 2 3 4

    Company Secretary

    AGMPH8323B

    9.

    Mr. Parth Kamdar14

    Company Secretary

    BSTPK0882Q

    10.

    Mr. Narendrakumar Patel5

    Non-Executive Director

    07017438

    5 Mr. Bhumishth Patel had been appointed as Managing Director, Mr. Narendrakumar Patel as
    Non-Executive Director, Mr. Dahyabhai Patel had given resignation from the post of Managing
    Director and Ms. Payal Patel had given resignation from Non-Executive Director w.e.f. 11th
    September, 2023.

    Apart from the above changes, there were no other changes in the composition of the Board of
    Directors of the Company during the Financial Year 2022-23 and till the date of Board's Report.

    As per Companies Act, 2013, the Independent Directors are not liable to retire by rotation.

    33. DECLARATION BY INDEPENDENT DIRECTORS:

    Mr. Pranav Vajani and Mr. Digesh Deshaval, Independent Directors of the Company have
    confirmed to the Board that they meet the criteria of Independence as specified under Section
    149 (6) of the Companies Act, 2013 and they qualify to be Independent Director. They have also
    confirmed that they meet the requirements of Independent Director as mentioned under
    Regulation 16 (1) (b) of SEBI (Listing Obligation and Disclosure Requirements) Regulations,
    2015. The confirmations were noted by the Board.

    34. CORPORATE GOVERNANCE:

    As per Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations,
    2015, quarterly compliance report on requirement Corporate Governance is not applicable to
    the Company.

    35. DEPOSITS:

    As per Section 73 of the Companies Act, 2013, the Company has neither accepted nor
    renewed any deposits during the financial year. Hence, the Company has not defaulted in
    repayment of deposits or payment of interest during the financial year.

    36. FORMAL ANNUAL EVALUATION PROCESS BY BOARD:

    Pursuant to the provisions of the Companies Act, 2013 and Rules made thereunder, the Board
    has carried the evaluation of its own performance, performance of Individual Directors, Board
    Committees, including the Chairman of the Board on the basis of attendance, contribution
    towards development of the Business and various other criteria as recommended by the
    Nomination and Remuneration Committee of the Company. The evaluation of the working of the
    Board, its committees, experience and expertise, performance of specific duties and obligations
    etc. were carried out. The Directors expressed their satisfaction with the evaluation process and
    outcome.

    In a separate meeting of Independent Directors, the performances of Executive and Non -
    Executive Directors were evaluated in terms of their contribution towards the growth and
    development of the Company. The achievements of the targeted goals and the achievements of
    the expansion plans were too observed and evaluated, the outcome of which was satisfactory for
    all the Directors of the Company.

    37. AUDITORS:A. Statutory Auditor:

    M/s. J. M. Patel & Bros., Chartered Accountants, Ahmedabad, (Firm Registration No.
    10770W), were appointed as the Statutory Auditors of the Company for the period of 4

    (Four) consecutive years from the conclusion of 9th Annual General Meeting held in the
    year 2019 till the conclusion of 13th Annual General Meeting of the Company to be held in
    the year 2023.

    The Auditor's report for the Financial Year ended 31st March, 2023 has been issued with
    an unmodified opinion, by the Statutory Auditor.

    B. Secretarial Auditor:

    The Board of Directors pursuant to Section 204 of the Companies Act, 2013 read with
    Rule 9 of the Companies (Appointment and Remuneration of Managerial Personnel)
    Rules, 2014, has appointed Mr. Gaurav Bachani, Proprietor of M/s. Gaurav Bachani &
    Associates, Company Secretaries, as a Secretarial Auditor of the Company to conduct
    Secretarial Audit for the Financial Year 2022-23.

    The Secretarial Audit Report for the Financial Year 2022-23 is annexed herewith as
    Annexure - III in Form MR-3. There are no adverse observations in the Secretarial Audit
    Report which call for explanation.

    C. Internal Auditor:

    The Board of directors has appointed M/s. H T A & Associates,., Chartered Accountants,
    as the internal auditor of the Company. The Internal Auditor conducts the internal audit
    of the functions and operations of the Company and reports to the Audit Committee and
    Board from time to time.

    38. DISCLOSURESA. Composition of Audit Committee:

    During the year under review, meetings of members of the Audit committee as tabulated
    below, was held on 30th May, 2022, 3rd September, 2022, 7th November, 2022 and 31st
    March, 2023 and the attendance records of the members of the Committee are as follows:

    Name

    Status

    No. of the

    No. of the

    Committee

    Committee

    Meetings entitled

    Meetings attended

    Mr. Pranav Vajani

    Chairperson

    4

    4

    Mr. Digesh Deshaval

    Member

    4

    4

    Ms. Payal Patel1

    Member

    4

    4

    Mr. Bhumishth Patel1

    Member

    NA

    NA

    B. Composition of Nomination and Remuneration Committee:

    During the year under review, meetings of the members of the Nomination and
    Remuneration committee, as tabulated below, was held on 3rd September, 2022 and the
    attendance records of the members of the Committee are as follows:

    Mr. Digesh Deshaval

    Chairperson

    1

    1

    Ms. Payal Patel1

    Member

    1

    1

    Mr. Narendrakumar Patel1

    Member

    NA

    NA

    Mr. Pranav Vajani

    Member

    1

    1

    C. Composition of Stakeholders' Relationship Committee:

    During the year under review, meetings of members of Stakeholders' Relationship
    committee as tabulated below, was held on 30th May, 2022 and 3rd September, 2022 and the
    attendance records of the members of the Committee are as follows:

    Name

    Status

    No. of the
    Committee
    Meetings entitled

    No. of the Committee
    Meetings attended

    Ms. Payal Patel1

    Chairman

    2

    2

    Mr. Narendrakumar
    Patel1

    Chairman

    NA

    NA

    Mr. Digesh Deshaval

    Member

    2

    2

    Mr. Pranav Vajani

    Member

    2

    2

    39. DISCLOSURES UNDER SEXUAL HARASSMENT OF WOMEN AT WORKPLACE
    (PREVENTION, PROHIBITION & REDRESSAL) ACT, 2013:

    The Company has always been committed to provide a safe and conducive work environment to
    its employees. Your Directors further state that during the year under review there were no
    cases filed pursuant to the Sexual Harassment of Women at Workplace (Prevention, Prohibition
    and Redressal) Act, 2013 as confirmed by the Internal Complaints Committee as constituted by
    the Company.

    40. INDUSTRIAL RELATIONS:

    The Directors are pleased to report that the relations between the employees and the
    management continued to remain cordial during the year under review.

    41. MAINTENANCE OF COST RECORDS:

    According to information and explanation given to us, the Central Government has not
    prescribed maintenance of cost records under section 148(1) of the Act in respect of activities
    carried out by the Company.

    42. THE DETAILS OF APPLICATION MADE OR ANY PROCEEDING PENDING UNDER THE
    INSOLVENCY AND BANKRUPTCY CODE, 2016:

    During the year under review, there were no applications made or proceedings pending in the
    name of the Company under the Insolvency and Bankruptcy Code 2016.

    43. THE DETAILS OF DIFFERENCE BETWEEN AMOUNT OF THE VALUATION DONE AT THE
    TIME OF ONE TIME SETTLEMENT AND THE VALUATION DONE WHILE AVAILING LOAN
    FROM THE BANKS AND FINANCIAL INSTITUTIONS:

    During the year under review, there has been no one time settlement of Loans taken from Banks
    and Financial Institutions.

    44. ACKNOWLEDGEMENTS

    Your Directors would like to express their sincere appreciation for the co-operation and
    assistance received from the Bankers, Regulatory Bodies, Stakeholders including Financial
    Institutions, Suppliers, Customers and other business associates who have extended their
    valuable sustained support and encouragement during the year under review.

    Your Directors take this opportunity to recognize and place on record their gratitude and
    appreciation for the commitment displayed by all executives, officers and staff at all levels of the
    Company. We look forward for the continued support of every stakeholder in the future.

    Registered Office: By the Order of the Board of

    A-1106, Empire Business Hub Near Evoq Remedies Limited

    AUDA Water Tank, Science City
    Road, Sola Ahmedabad, Gujarat -
    380 060

    Sd/- Sd/-Narendrakumar Patel Bhumishth PatelPlace: Ahmedabad Director Managing DirectorDate: 11th September, 2023 DIN: 07017438 DIN: 02516641

    1

    Mr. Tej Hanj had given resignation from the post of Company Secretary and Mr. Parth
    Kamdar had been appointed as Company Secretary w.e.f. 3rd September, 2022.

    2

    Mr. Bhumishth Patel had given resignation from the post of Managing Director w.e.f. 31st
    March, 2023.

    3

    Mr. Tarunkumar Patel had given resignation from the post of Non-Executive Director and Mr.
    Dahyabhai Patel had been appointed as Managing Director w.e.f. 25th May, 2023.

    4

    Mr. Parth Kamdar had given resignation from the post of Company Secretary w.e.f 12th July,
    2023.

  • Evoq Remedies Ltd.

    Company News



    Market Cap.(`) 14.36 Cr. P/BV 0.58 Book Value (`) 18.22
    52 Week High/Low ( ` ) 19/9 FV/ML 10/4000 P/E(X) 8.87
    Book Closure EPS (`) 1.19 Div Yield (%) 0.00
    You can view the latest news of the Company.

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |     |  ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.   |  "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors"   |  ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600   |  For any Grievance mail to : grievance@sharewealthindia.com   |  For any DP Grievance mail to : dpgrievance@sharewealthindia.com.   |  Grievance with SEBI : https://scores.gov.in/scores/Welcome.html